Avantor, Inc. (AVTR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
AVTR looks worth holding as its broad portfolio, strategic deals and cost savings offset Lab Solutions' weakness for now with AI tools and strong cash flow.
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Investors need to pay close attention to AVTR stock based on the movements in the options market lately.
AVTR's Q3 earnings and revenue fell short of estimates, leading the company to cut its full-year 2025 outlook.
Avantor, Inc. ( AVTR ) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Company Participants Allison Hosak - Senior VP of Global Communications & Brand Emmanuel Ligner - President & CEO R. Jones - Executive VP & CFO Conference Call Participants Vijay Kumar - Evercore ISI Institutional Equities, Research Division Michael Ryskin - BofA Securities, Research Division Daniel Brennan - TD Cowen, Research Division Luke Sergott - Barclays Bank PLC, Research Division Tycho Peterson - Jefferies LLC, Research Division Patrick Donnelly - Citigroup Inc., Research Division Douglas Schenkel - Wolfe Research, LLC Daniel Leonard - UBS Investment Bank, Research Division Presentation Operator Good morning.
The headline numbers for Avantor (AVTR) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.26 per share a year ago.
Avantor (AVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AVTR collaborates with BlueWhale Bio to speed CAR-T manufacturing using CDNP tech, aiming to scale production and expand patient access.
Engine believes that Avantor's significant underperformance is a consequence of self-inflicted mistakes rooted in a flawed leadership team and framework.